trending Market Intelligence /marketintelligence/en/news-insights/trending/roqrwyuwdflihokjx4wv4a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aileron Therapeutics appoints chairman

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aileron Therapeutics appoints chairman

Aileron Therapeutics, Inc. appointed Jeffrey Bailey as chairman of its board of directors.

Bailey serves as CEO and director of privately held device maker IlluminOss Medical, Inc.

He is also a director at Madison Vaccines, Inc.

Bailey replaces Scott Kapnick as chairman of the Cambridge, Mass.-based biotechnology company. Kapnick will remain on the company's board.

In addition, Aileron said Brian Gallagher Jr. resigned from the company's board.